--- title: Cost of FDA SaMD Post-Market Surveillance for AI Medical Devices description: Explore the costs and requirements of FDA post-market surveillance for AI medical devices at community hospitals, ensuring compliance and safety. image: https://blog.fivenines.com/hubfs/blog/taya-migration/71-fda-samd-post-market-cost-cqo.docx.png --- [Skip to the main content.](https://blog.fivenines.com/cost-of-fda-samd-post-market-surveillance-for-ai-medical-devices#main-content) 1-855-817-5959    [help@fivenines.com](mailto:help@fivenines.com) [![FN\_Reverse\_Logo](https://blog.fivenines.com/hs-fs/hubfs/FN_Reverse_Logo.png?width=3022&height=849&name=FN_Reverse_Logo.png "FN_Reverse_Logo")](https://fivenines.com/) [![FiveNinesPrimaryLogo](https://blog.fivenines.com/hs-fs/hubfs/FiveNinesPrimaryLogo.png?width=3022&height=849&name=FiveNinesPrimaryLogo.png "FiveNinesPrimaryLogo")](https://fivenines.com/) - [Solutions](https://fivenines.com/solutions/) - [Managed IT Services](https://fivenines.com/solutions/managed-it-services/) - [Cybersecurity Services](https://fivenines.com/solutions/cybersecurity/) - [Cloud & Productivity](https://fivenines.com/solutions/cloud-productivity/) - [Projects & Enhancements](https://fivenines.com/solutions/it-projects/) - [Placement Services](https://fivenines.com/solutions/onsite-it/) - Industries - [Finance & Banking](https://fivenines.com/industries/banking/) - [Healthcare](https://fivenines.com/industries/healthcare/) - [Legal](https://fivenines.com/industries/legal/) - [Nonprofit](https://fivenines.com/industries/non-profit/) - [Manufacturing & Logistics](https://fivenines.com/industries/manufacturing-logistics/) - [Small & Mid-Sized Businesses](https://fivenines.com/industries/smb/) - [Insights](https://fivenines.com/resources/) - [Resource Library](https://fivenines.com/resources/) - [Blog](https://blog.fivenines.com) - [About](https://fivenines.com/about/) - [About Five Nines](https://fivenines.com/about/) - [Leadership Team](https://fivenines.com/our-team/) - [Community Impact](https://fivenines.com/community/) - [Partnerships](https://fivenines.com/partnerships/) - [Careers](https://fivenines.com/careers/) - [Company News](https://fivenines.com/news/) Let's Talk Get Support Toggle Menu Toggle Menu Let's Talk Get Support - [Solutions](https://fivenines.com/solutions/) - [Managed IT Services](https://fivenines.com/solutions/managed-it-services/) - [Cybersecurity Services](https://fivenines.com/solutions/cybersecurity/) - [Cloud & Productivity](https://fivenines.com/solutions/cloud-productivity/) - [Projects & Enhancements](https://fivenines.com/solutions/it-projects/) - [Placement Services](https://fivenines.com/solutions/onsite-it/) - Industries - [Finance & Banking](https://fivenines.com/industries/banking/) - [Healthcare](https://fivenines.com/industries/healthcare/) - [Legal](https://fivenines.com/industries/legal/) - [Nonprofit](https://fivenines.com/industries/non-profit/) - [Manufacturing & Logistics](https://fivenines.com/industries/manufacturing-logistics/) - [Small & Mid-Sized Businesses](https://fivenines.com/industries/smb/) - [Insights](https://fivenines.com/resources/) - [Resource Library](https://fivenines.com/resources/) - [Blog](https://blog.fivenines.com) - [About](https://fivenines.com/about/) - [About Five Nines](https://fivenines.com/about/) - [Leadership Team](https://fivenines.com/our-team/) - [Community Impact](https://fivenines.com/community/) - [Partnerships](https://fivenines.com/partnerships/) - [Careers](https://fivenines.com/careers/) - [Company News](https://fivenines.com/news/) # Cost of FDA SaMD Post-Market Surveillance for AI Medical Devices [Five Nines Executive Team](https://blog.fivenines.com/author/five-nines-executive-team) : Nov 12, 2026, 6:00:00 AM 2 min read [Healthcare](https://blog.fivenines.com/topic/healthcare) [Tech Operations Insights](https://blog.fivenines.com/topic/tech-operations-insights) [AI](https://blog.fivenines.com/topic/ai) [Clinical IT](https://blog.fivenines.com/topic/clinical-it) ![Cost of FDA SaMD Post-Market Surveillance for AI Medical Devices](https://blog.fivenines.com/hubfs/blog/taya-migration/71-fda-samd-post-market-cost-cqo.docx.png) *TL;DR* - Hospitals deploying FDA-cleared AI medical devices inherit post-market surveillance obligations. FDA's January 2025 PCCP (Predetermined Change Control Plan) guidance sets expectations for monitoring AI device performance, capturing adverse events, and engaging with manufacturers on device updates. Cost at community hospital scale is moderate but real. - Annual cost for substantive post-market surveillance of AI medical devices at a community hospital with three to six AI devices lands in the mid five figures. Cost includes device inventory, performance monitoring, adverse event reporting, manufacturer coordination, and clinical governance. - The CQO question is not whether to perform post-market surveillance. FDA expects it. The question is whether the program operates at the depth that supports device safety and FDA examination response. ## What FDA Post-Market Surveillance Requires for AI Medical Devices A community hospital CQO with FDA-cleared AI medical devices in clinical use operates against FDA post-market surveillance expectations. The January 2025 PCCP guidance sharpened the expectations for AI devices specifically. What follows is the plain-English version.   ## What FDA Actually Expects From Post-Market AI Device Surveillance FDA post-market surveillance applies to all medical devices. For AI devices, specific considerations include: - Performance monitoring. AI device performance can drift in production. Hospitals should monitor whether device behavior matches authorized use. - PCCP envelope monitoring. Devices authorized with Predetermined Change Control Plans can update post-market within a defined envelope. Hospitals monitor whether updates stay within envelope. - Adverse event reporting. Medical Device Reporting (MDR) requirements apply to AI device adverse events. - Manufacturer coordination. Manufacturers update AI devices over time. Hospital coordination on updates supports continued safe use. - Clinical governance. Hospital clinical leadership owns device use governance, with the quality function supporting.   ## The Five Cost Components of AI Device Post-Market Surveillance 1. Device inventory. Per-device tracking with risk tier, FDA clearance details, and PCCP status. Annual: low five figures. 2. Performance monitoring. Clinical outcome tracking for AI device-assisted decisions. Annual: low to mid five figures. 3. Adverse event capture. MDR-compliant adverse event tracking. Modest dollar; meaningful clinical engagement. 4. Manufacturer coordination. Vendor engagement on updates, attestation review. Modest dollar. 5. Clinical governance. Medical staff engagement on AI device use. Time-driven cost. Total annual cost: mid five figures at community hospital scale.   ## What the CQO Controls in Post-Market Surveillance The CQO controls four things in post-market surveillance. The first is the device inventory. Every FDA-cleared AI device in clinical use should appear. The second is the performance monitoring methodology. Clinical outcome tracking should produce data the bank can act on. The third is the adverse event response. The MDR pathway must operate when events occur. The fourth is the manufacturer relationship. Open engagement on device updates supports continued safe use.   ## Three Things to Work Through Before the Next FDA Interaction A community hospital CQO should work through three things on AI device post-market surveillance. The first is a device inventory refresh. The second is performance monitoring methodology. The third is adverse event response readiness.   ## Operate Post-Market Surveillance at the Depth FDA's AI Device Framework Expects A community hospital CQO operating FDA SaMD post-market surveillance is operating against the framework FDA examines. The cost is moderate. If your hospital has not assessed AI device post-market surveillance in the last twelve months, that is the conversation worth having with your Tech-Operations partner before the next FDA inspection cycle. Five Nines Technology Group is a Tech-Operations partner for community hospitals, clinics, and health systems. Translating regulatory frameworks into operating discipline at community hospital scale is where our team focuses. ## Frequently asked questions Does FDA examine post-market surveillance at hospitals? FDA inspects under MDR compliance. Hospitals using AI devices face inquiries on adverse event handling. Can the manufacturer handle most surveillance work? Manufacturer information flows to the hospital. The hospital's clinical use generates the data the manufacturer needs and the hospital's responsibility. How does PCCP affect post-market surveillance? PCCP defines the envelope within which manufacturers can update without new FDA submission. Hospitals monitor whether updates stay within envelope. What is the MDR threshold for AI devices? The same threshold as other medical devices: death, serious injury, or malfunction that could lead to either. What is the most common post-market surveillance gap? Performance monitoring depth. Hospitals deploy AI devices without ongoing clinical outcome tracking. ## Related Blog Posts ## Let's get in touch   [**(402) 817-2630**](tel:402-817-2630) [help@fivenines.com](mailto:help@fivenines.com) [Lincoln, NE](https://fivenines.com/contact/lincoln) [Omaha, NE](https://fivenines.com/contact/omaha) [Kearney, NE](https://fivenines.com/contact/kearney) [Central City, NE](https://fivenines.com/contact/central-city) [St. Louis, MO](https://fivenines.com/st-louis) ![cyberverify-1](https://blog.fivenines.com/hs-fs/hubfs/cyberverify-1.png?width=110&height=110&name=cyberverify-1.png)![aicpa](https://blog.fivenines.com/hs-fs/hubfs/aicpa.png?width=110&height=110&name=aicpa.png) ### Are we a good fit? [![Schedule Consultation](https://no-cache.hubspot.com/cta/default/1857420/interactive-196258273705.png)](https://blog.fivenines.com/hs/cta/wi/redirect?encryptedPayload=AVxigLLJWFOMaDFx3Y%2BcX75mvBPU6LYpsBfrocd2H9Vcqzy%2BHajUWJy5nULtGigNImIiezs25dBu%2BA3p9%2BvZ5c6H8gEF3SlrWY3XBSED7gfTWAw7XJ5JJadZ6yuy0cYVJHHH7QmTYxoKnT2XbhxG7Eemkhh2a0n3WteI%2Bd%2BmilxtIE5KbwPBzmnCzSrJ%2B%2FgmWV5VnRZoBQ%3D%3D&webInteractiveContentId=196258273705&portalId=1857420)   - [Privacy Policy](https://fivenines.com/privacy-policy/) - [HTML Sitemap](https://fivenines.com/html-sitemap/) © 2026 Five Nines Technology Group | 5617 Thompson Creek Blvd Lincoln, NE 68516 [Facebook](https://www.facebook.com/gonines)[Linkedin](https://www.linkedin.com/company/five-nines-technology-group/) [Blog](https://blog.gonines.com/?__hstc=143714730.45718742b0726c421d8592d7ea71f58b.1757514685996.1758029308186.1758134756251.4&__hssc=143714730.31.1758134756251&__hsfp=1745665186)   [Client Support](https://fivenines.com/client-login/) Return to top ```json { "@context" : "https://schema.org", "@type" : "FAQPage", "mainEntity" : [ { "@type" : "Question", "acceptedAnswer" : { "@type" : "Answer", "text" : "FDA inspects under MDR compliance. Hospitals using AI devices face inquiries on adverse event handling." }, "name" : "Does FDA examine post-market surveillance at hospitals?" }, { "@type" : "Question", "acceptedAnswer" : { "@type" : "Answer", "text" : "Manufacturer information flows to the hospital. The hospital's clinical use generates the data the manufacturer needs and the hospital's responsibility." }, "name" : "Can the manufacturer handle most surveillance work?" }, { "@type" : "Question", "acceptedAnswer" : { "@type" : "Answer", "text" : "PCCP defines the envelope within which manufacturers can update without new FDA submission. Hospitals monitor whether updates stay within envelope." }, "name" : "How does PCCP affect post-market surveillance?" }, { "@type" : "Question", "acceptedAnswer" : { "@type" : "Answer", "text" : "The same threshold as other medical devices: death, serious injury, or malfunction that could lead to either." }, "name" : "What is the MDR threshold for AI devices?" }, { "@type" : "Question", "acceptedAnswer" : { "@type" : "Answer", "text" : "Performance monitoring depth. Hospitals deploy AI devices without ongoing clinical outcome tracking." }, "name" : "What is the most common post-market surveillance gap?" } ] } ```